Blogs » Health » Virtual Clinical Trials Market Size, Segments, Industry Growth,

Virtual Clinical Trials Market Size, Segments, Industry Growth,

  • According to MRFR analysis, the global virtual clinical trials market is expected to register a CAGR of ~5.89% during the forecast period of 2021 to 2027 and is expected to reach ~USD 11,239.0 million by 2027.

    Virtual clinical trials market are method of conducting clinical research using apps, electronically monitoring devices and online social engagement platforms. In 2020, 76% of more than 200 clinical trial sponsors said they conducted most or all of their patient monitoring remotely, up from only 18% of respondents the previous year, according to the 2021 State of the Industry Report from Florence Healthcare (US), a provider of digital research workflows and remote site access. This exponential increase in number of clinical trials monitored digitally is expected to increase the growth of global virtual clinical trials market during the forecast period.

    The global virtual clinical trials market is currently dominated by several market players. The key players are involved in geographic expansion, acquisition, and strategic collaborations to maintain their global footprint in the global clinical trials market. For instance, in June 2020, Tabula Rasa HealthCare (US), a New Jersey-based company collaborated with Washington-based health plan provider Regence (US) to virtually trial several different COVID-19 drug candidates and assess the risk of adverse drug events.

    Segmentation

    The global virtual clinical trials market has been segmented based on study type, phase, and indication.

    By Study Type

    • Interventional
    • Observational
    • Others

    By Phase

    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4

    By Indication

    • Oncology
    • Cardiovascular
    • Immunology
    • Gastrointestinal
    • Respiratory
    • Endocrinology
    • Ophthalmology
    • Others

    Key Players

    Some of the key players in the global virtual clinical trials market are Oracle Corporation (US), IQVIA Holdings, Inc. (US), Dassault Systemes SE (France), Medpace Holdings, Inc. (US), Icon plc (Ireland), Laboratory Corporation of America Holdings (US), Parexel International Corporation (US), Medable, Inc. (US), Clinical Ink, Inc. (US), Wuxi AppTech (China), and Medable, Inc. (US) among others.

    Regional Analysis

    The market has been divided, by region, into the North America, Europe, Asia-Pacific, and Rest of the World.

    North America is anticipated to hold the largest market share owing to availability of major players operating in the region. Medable, Inc. (US), Oracle Corporation (US), IQVIA Holdings, Inc. (US), Syneos Health (US), PPD, Inc. (US) and Medpace Holdings, Inc. (US) are some of the notable companies operating in the region. Moreover, collaborative approach by companies operating in the region were observed due to rising demand and continuation of early phase clinical studying during the pandemic. For instance, during October 2020, FHI Clinical Inc. (US), a contract research organization adopted Oracle’s (US) Oracle Health Sciences Clinical One, a cloud platform for effective study management throughout the entire drug development lifecycle.

    European virtual clinical trials market has been categorized into Germany, France, the UK, Italy, Spain, and the rest of Europe. Europe is anticipated to hold the significant market share owing to investment activities related to clinical trials in the region and support from government for R&D. For example, Parexel International Corporation (US) in November 2020 announced a strategic partnership between its Early Phase Clinical Unit (Germany) and Clinical Trial Center (CTC) North, a full-service CRO located at the University Medical Center Hamburg-Eppendorf (Germany). Parexel intends to roll-out and implement eSource system ClinBase at CTC North to drive efficiency.

    The virtual clinical trials market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The growth of virtual clinical trials market in Asia-Pacific is anticipated to witness rapid growth during the forecast period owing to increasing number of memorandum signed by governmental agencies to promote research activities. For example, India and the UK announced a new memorandum of understanding in November 2020 between the Central Drugs Standard Control Organisation (India) and the UK Medicines and Healthcare Products Regulatory Agency.

    About Market Research Future:

    At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

    Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. 

    Contact us:

    Market Research Future (part of Wantstats Research and Media Private Limited), 

    99 Hudson Street,5Th Floor, New York, New York 10013, 

    United States of America

    +1 646 845 9312

    Email: sales@marketresearchfuture.com